Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 17, 2024 OWNERSHIP DOCUMENT
SC 13D/A Sep 17, 2024 SC 13D/A
424B5 Sep 13, 2024 424B5
8-K Sep 12, 2024 8-K
424B5 Sep 10, 2024 424B5
8-K Sep 10, 2024 8-K
S-8 Aug 12, 2024 S-8
8-K Aug 8, 2024 8-K
10-Q Aug 8, 2024 10-Q
8-K Jul 15, 2024 8-K
4 Jun 28, 2024 4
4 Jun 28, 2024 4
4 Jun 28, 2024 4
4 Jun 28, 2024 4
4 Jun 28, 2024 4
8-K Jun 20, 2024 8-K
DEFA14A Jun 10, 2024 DEFA14A
10-Q May 8, 2024 10-Q
8-K May 8, 2024 8-K
ARS Apr 26, 2024 ARS
DEFA14A Apr 26, 2024 DEFA14A
DEF 14A Apr 26, 2024 DEF 14A
8-K Apr 16, 2024 8-K
SC 13D/A Apr 1, 2024 SC 13D/A
4 Apr 1, 2024 4
← Newer Page 6 of 33 · 815 filings Older →